{"filing":{"accession_number":"0001793229-26-000061","cik":"0001793229","ticker":"CTEV","company_name":"Claritev Corp","form":"8-K","filing_date":"2026-07-06","report_date":null,"primary_document":"ctev-20260706.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1793229/000179322926000061/ctev-20260706.htm"},"events":[{"id":17128,"run_id":15332,"accession_number":"0001793229-26-000061","anchor_item_number":"8.01","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Mr. John Prince's death results in his departure from the Claritev Board of Directors, where he served since June 2023 and held a position on the Audit Committee. While disclosed under Item 8.01 (Other Information) rather than the typical Item 5.02, the substance is a director departure due to death, which is material to investors assessing board composition and audit oversight.","company_name":"Claritev Corp","ticker":"CTEV","filing_date":"2026-07-06","form":"8-K","submitted_at":null,"items":[{"id":15462,"accession_number":"0001793229-26-000061","item_number":"8.01","item_title":"Other Information","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Mr. John Prince's death results in his departure from the Claritev Board of Directors, where he served since June 2023 and held a position on the Audit Committee. While disclosed under Item 8.01 (Other Information) rather than the typical Item 5.02, the substance is a director departure due to death, which is material to investors assessing board composition and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T12:54:18.434184+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15462,"accession_number":"0001793229-26-000061","item_number":"8.01","item_title":"Other Information","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Mr. John Prince's death results in his departure from the Claritev Board of Directors, where he served since June 2023 and held a position on the Audit Committee. While disclosed under Item 8.01 (Other Information) rather than the typical Item 5.02, the substance is a director departure due to death, which is material to investors assessing board composition and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T12:54:18.434184+00:00","company_name":"Claritev Corp","ticker":"CTEV","filing_date":"2026-07-06"}]}